Regeneron's science chief on starting clinical trials for Covid-19 antibody drug

Dr. George Yancopoulos, chief scientific officer at Regeneron, joins CNBC's Meg Tirrell and the "Squawk Box" crew to discuss the company's start of the first clinical trials for its Covid-19 antibody drug.